Citation: | GAO Ying, GAO Xiong. Correlation of insulin management during pregnancy and childbirth with neonatal hypoglycemia in pregnant women with diabetes[J]. Journal of Clinical Medicine in Practice, 2024, 28(16): 104-108. DOI: 10.7619/jcmp.20241078 |
To investigate the efficacy of intravenous insulin infusion for pregnant women with diabetes during childbirth for blood glucose control and the influence of diabetes management during pregnancy and childbirth on neonatal hypoglycemia.
Clinical materials of 100 pregnant women with diabetes receiving antenatal care in the Department of Gynecology and Obstetrics in the Northern Jiangsu People's Hospital Affiliated to Yangzhou University from January 2022 to December 2023 were retrospectively analyzed.
Hypoglycemia (blood glucose < 2.2 mmol/L) was observed in 65 neonates delivered by the pregnant women, and 46 neonates delivered by the pregnant women required intravenous glucose therapy. There was a significant correlation between maternal blood glucose>7.0 mmol/L during childbirth and the occurrence of neonatal hypoglycemia (P=0.034), but these cases did not require intravenous glucose therapy or transferring to the neonatal intensive care unit. Glycated hemoglobin (HbA1c) >6.5% in the third trimester in diabetic pregnant women was correlated with the need for intervention in neonatal hypoglycemia (OR=3.89, 95%CI, 1.42 to 10.68).
Maternal blood glucose>7.0 mmol/L during childbirth can predict neonatal hypoglycemia but is not associated with its severity. Elevated HbA1c in the third trimester reflects maternal hyperglycemia and predicts severe neonatal hyperinsulinemia with proactive interventions. Maintaining HbA1c < 6.5% in the third trimester is crucial for improving neonatal hypoglycemia.
[1] |
CAO Y, YANG Y, LIU L, et al. Analysis of risk factors of neonatal hypoglycemia and its correlation with blood glucose control of gestational diabetes mellitus: a retrospective study[J]. Medicine, 2023, 102(35): e34619.
|
[2] |
US Preventive Services Task Force, DAVIDSON K W, BARRY M J, et al. Screening for gestational diabetes: us preventive services task force recommendation statement[J]. JAMA, 2021, 326(6): 531-538.
|
[3] |
YAMAMOTO J M, DONOVAN L E, MOHAMMAD K, et al. Severe neonatal hypoglycaemia and intrapartum glycaemic control in pregnancies complicated by type 1, type 2 and gestational diabetes[J]. Diabet Med, 2020, 37(1): 138-146.
|
[4] |
THEVARAJAH A, SIMMONS D. Risk factors and outcomes for neonatal hypoglycaemia and neonatal hyperbilirubinaemia in pregnancies complicated by gestational diabetes mellitus: a single centre retrospective 3-year review[J]. Diabet Med, 2019, 36(9): 1109-1117.
|
[5] |
FERRARA A, WEISS N S, HEDDERSON M M, et al. Pregnancy plasma glucose levels exceeding the American Diabetes Association thresholds, but below the National Diabetes Data Group thresholds for gestational diabetes mellitus, are related to the risk of neonatal macrosomia, hypoglycaemia and hyperbilirubinaemia[J]. Diabetologia, 2007, 50(2): 298-306.
|
[6] |
WEST T E, LOWY C. Control of blood glucose during labour in diabetic women with combined glucose and low-dose insulin infusion[J]. Br Med J, 1977, 1(6071): 1252-1254.
|
[7] |
ELSAYED N A, ALEPPO G, ARODA V R, et al. 15. management of diabetes in pregnancy: standards of care in diabetes-2023[J]. Diabetes Care, 2023, 46(Suppl 1): S254-S266.
|
[8] |
DASHORA U, MURPHY H R, TEMPLE R C, et al. Managing hyperglycaemia during antenatal steroid administration, labour and birth in pregnant women with diabetes[J]. Diabet Med, 2018, 35(8): 1005-1010.
|
[9] |
黄国英, 王天有. 儿科学[M]. 2版. 北京: 人民卫生出版社, 2022: 134-134.
|
[10] |
EDWARDS T, ALSWEILER J M, GAMBLE G D, et al. Neurocognitive outcomes at age 2 years after neonatal hypoglycemia in a cohort of participants from the hPOD randomized trial[J]. JAMA Netw Open, 2022, 5(10): e2235989.
|
[11] |
BUCHANAN T A, XIANG A H, PAGE K A. Gestational diabetes mellitus: risks and management during and after pregnancy[J]. Nat Rev Endocrinol, 2012, 8(11): 639-649.
|
[12] |
JOVANOVIC L. Glucose and insulin requirements during labor and delivery: the case for normoglycemia in pregnancies complicated by diabetes[J]. Endocr Pract, 2004, 10(Suppl 2): 40-45.
|
[13] |
TASCHETTO A P D, ZIMATH P L, SILVÉRIO R, et al. Reduced insulin sensitivity and increased β/α cell mass is associated with reduced hepatic insulin-degrading enzyme activity in pregnant rats[J]. Life Sci, 2021, 277: 119509.
|
[14] |
Group of Neonatology P S. Expert consensus on standard clinical management of neonatal hypoglycemia in China (2021)[J]. Zhongguo Dang Dai Er Ke Za Zhi, 2022, 24(1): 1-13.
|
[15] |
HOERMANN H, MOKWA A, ROEPER M, et al. Reliability and observer dependence of signs of neonatal hypoglycemia[J]. J Pediatr, 2022, 245: 22-29, e2.
|
[16] |
MITANCHEZ D, YZYDORCZYK C, SIDDEEK B, et al. The offspring of the diabetic mother: short- and long-term implications[J]. Best Pract Res Clin Obstet Gynaecol, 2015, 29(2): 256-269.
|
[17] |
DUDE A M, DREXLER K, YEE L M. Glycosylated hemoglobin A1c prior to delivery and neonatal hypoglycemia in pregnancies complicated by diabetes[J]. Am J Obstet Gynecol MFM, 2022, 4(5): 100670.
|
[18] |
MATHIESEN E R, RINGHOLM L, DAMM P. Pregnancy management of women with pregestational diabetes[J]. Endocrinol Metab Clin North Am, 2011, 40(4): 727-738.
|
[19] |
ALEXOPOULOS A S, BLAIR R, PETERS A L. Management of preexisting diabetes in pregnancy: a review[J]. JAMA, 2019, 321(18): 1811-1819.
|